Clinical trial · Observational
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
Registry Study of T Cell Depleted Allogeneic Non-Myeloablative Stem Cell Transplant Recipients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Allogeneic transplantation is used to treat many malignant and non-malignant diseases. The investigators and others have shown that less toxic preparative regimens (reduced intensity or 'mini' transplants) allow reliable allogeneic engraftment and durable remissions, significantly broadening the population of patients who may be offered this therapy to those who are older and more infirmed. The field is now focusing on the period post transplant for approaches to immune recovery leading to improved outcomes. The primary objective of this registry is to catalogue data from patients who undergo standard of care reduced intensity allogeneic transplantation.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hodgkin's Disease | Hodgkin Lymphoma | ALIAS | 0.90 |
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
| Myelodysplasia | Myelodysplastic Syndrome | ALIAS | 0.90 |
| Myeloma | Multiple Myeloma | ALIAS | 0.90 |
| Non Hodgkin's Lymphoma | Non-Hodgkin Lymphoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Reduced Intensity Allogeneic Transplant
- description
- Subjects undergoing a reduced intensity allogeneic stem cell transplant
Primary outcomes (1)
- measure
- Catalogue Data
- timeFrame
- 1 year
- description
- Catalogue data from subjects who undergo standard of care reduced intensity allogeneic transplantation.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Recipient Inclusion Criteria: * Subjects ≥ 18 years of age undergoing a reduced intensity allogeneic transplant Exclusion Criteria: * Subjects \< 18 years of age * Subjects not undergoing nonmyeloablative or ablative allogeneic transplant
References
Publications (0)
Data not yet available